Forte Biosciences Files 2025 DEF 14A
Ticker: FBRX · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1419041
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: FBRX
TL;DR
Forte Bio (FBRX) DEF 14A out - exec comp & governance details.
AI Summary
Forte Biosciences, Inc. filed a DEF 14A on April 30, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, formerly known as Tocagen Inc., is based in Dallas, TX, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides crucial information for shareholders regarding executive compensation, board composition, and voting matters, impacting corporate governance and investor relations.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing detailing executive compensation and corporate governance, not indicating immediate financial distress or significant new risks.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
- 20250430 — Filing Date (Date the DEF 14A was filed with the SEC.)
Key Players & Entities
- Forte Biosciences, Inc. (company) — Filer
- Tocagen Inc. (company) — Former company name
- Dallas, TX (location) — Business address
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is the period of report for this DEF 14A filing?
The conformed period of report for this DEF 14A filing is May 29, 2025.
What was Forte Biosciences, Inc. formerly known as?
Forte Biosciences, Inc. was formerly known as Tocagen Inc., with a date of name change on November 20, 2007.
What is Forte Biosciences, Inc.'s Standard Industrial Classification code?
Forte Biosciences, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Forte Biosciences, Inc. located?
Forte Biosciences, Inc.'s business and mailing address is 3060 Pegasus Park Drive, Building 6, Dallas, TX 75247.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Forte Biosciences, Inc. (FBRX).